Blog - Page 4 of 7

CASE STUDY: Building a US sales team for a startup aligner manufacturer

16th November 2021 by Russell Stones

Posted in Case Studies, Dental, Medical Devices, Startups

A startup aligner manufacturer was looking to launch in the US and as part of its ambitious growth plans, the company needed to establish a field sales team. These roles have been critical to the US growth of the startup and one of our candidates is the top performing sales representative in the business.

Are companies willing to reduce travel for sales and field-based employees?

30th September 2021 by Oliver Baumgart

Posted in HR, Scientific and Process Technology

Covid-19 has undeniably changed the way we live, work and communicate. For sales, field service and field application employees, travel restrictions have given an insight into a new way of working. As a result, we are seeing an increasing trend of people looking for a better balance, but is this something companies are willing to offer?

Addressing the post-Brexit hiring challenges of UK Qualified Persons

23rd September 2021 by Christine Sands

Posted in Pharmaceuticals

Before Brexit, the UK could hire QPs from any location within the EU, but now we can only hire QPs based in the UK – resulting in a lack of supply and a rise in day-rates and salaries. We spoke to the Vice President of Quality at a global biotechnology organisation about the challenges of hiring QPs within the UK, and how these might be overcome.

Should you ever accept a counteroffer?

8th September 2021 by Thomas Jones

Posted in Job Search

50% of employees receive a counteroffer when they resign. For your employer, it’s undoubtedly a costly process to recruit your replacement and it is only natural they would try to keep you. But should you ever accept and can the underlying issues that prompted you to explore new opportunities in the first place be resolved by a counteroffer?

What life science companies should consider for a US expansion

1st September 2021 by James Chippindale

Posted in International Expansion, Medical Devices, Pharmaceuticals, Scientific and Process Technology

Are you a life science company looking to expand into the US? To find out more about what you should consider, we interviewed Joanne Farquharson, President & Chief Executive Officer at Foothold America, a company that helps businesses around the world to expand into the US market.

Attracting and retaining talent during the turnover tsunami

7th July 2021 by Christine Sands

Posted in HR

In the US, we are beginning to see the start of the predicted ‘turnover tsunami’ and it might not be long until we see something similar across Europe and the UK. But why is this happening and what can employers do to not only retain existing employees but to also attract those individuals looking for a change of career?

CASE STUDY: Generic Pharma Company’s US Expansion

14th June 2021 by Christine Sands

Posted in Case Studies, International Expansion, Pharmaceuticals

An established pharmaceutical company in Europe that develops, manufactures and markets generic medications planned to continue its growth strategy by opening a new subsidiary to target the US generics market. To develop and commercialise a portfolio of generic drugs to market, the company needed a US General Manager.

How to manage impostor syndrome

9th June 2021 by Oliver Baumgart

Posted in HR

Have you ever felt like you are out of your depth or can’t do the job you’ve been hired to do? Do you worry you will be discovered at any point as a ‘fraud’? You may be suffering from impostor syndrome: a phenomenon where an individual doubts their skills, talents, abilities, and accomplishments in the face of obvious success.

Will Covid-19 increase US biosimilar adoption in 2021?

14th April 2021 by Ben Conway

Posted in Pharmaceuticals

In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?

Our blog

Filters: